Skip to main content

Programme

Friday April 17th - CEST Timezone

08:00 - 09:00
Non-Sponsored Symposia
08:00
MR - D9
Musculoskeletal Aging: where East meets West
Chairperson: Elaine Dennison
08:00
MR - D9
Musculoskeletal aging in the oldest old: when East meets West
Elaine Dennison
08:00
MR - D9
The ROAD study: an overview
Noriko Yoshimura
08:00
MR - D9
The SALSA study: an overview
Faidra Laskou
08:00
MR - D9
How does musculoskeletal health and its determinants in East and West differ?
Leo Westbury
08:00
MR - D8
Cardiovascular Comorbidities in Osteoporosis: WHO Report
Chairperson: Peter Ebeling
08:00
MR - D8
Move to Improve: Osteoporosis, Cardiovascular Risk, and the Role of Exercise in Healthy Aging
Cassandra Smith
08:00
MR - D8
Bone Appetit: Influence of Cardiovascular Disease on Musculoskeletal Health: A Kev Role for Nutrition?
Marc Sim
08:00
MR - D8
A Model of Atherosclerotic Calcifications as a Consequence of Osteoporosis
Gordon Klein
08:00
MR - D8
Q&A
08:00
MR - D3
The metabolic profile of psoriatic disease. Obesity, musculoskeletal manifestations and management
Chairperson: Panagiotis Athanassiou
08:00
MR - D3
Psoriatic disease
Lambros Athanassiou
08:00
MR - D3
Psoriatic disease and metabolic syndrome
Dionyssiotis Yannis
08:00
MR - D3
Psoriatic disease and obesity
Yannis Athanassiou, Ifigenia Kostoglou-Athanassiou
08:00
MR - D3
Psoriatic disease and treatment
Panagiotis Athanassiou
08:00
MR- D4
Standardizing Periprosthetic DA in Hip and Knee Arthroplasty: From Variability to Robust Data
Chairpersons: Jose Francisco Torres-Naranjo, Cristina Ojeda-Thies
08:00
MR- D4
Why Periprosthetic DXA Needs Standardization: Evidence, Variability, and the RAND/UCLA Process
Jose Francisco Torres-Naranjo
08:00
MR- D4
From Pixels to Protocols: A Practical Framework for High-Quality Periprosthetic DXA
Maria Silvia Larroudé
08:00
MR- D4
Interpreting Perprosthetic BMD: Precision, Longitudinal Change, and Therapy-Aware Flags
Roberto Enrique Lopez-Cervantes
08:00
MR - D1
Capture the Fracture® - Building High-Quality Fracture Liaison Services: Practical Lessons from Global Experience
Chairperson: Maria Luisa Brandi
08:00
MR - D1
The FLS history in Italy: A decade of action
Maria Luisa Brandi
08:00
MR - D1
Learning from peers and building a strong FLS community – the Japanese experience
Atsushi Suzuki
08:00
MR - D1
A set of variables for the assessment of Fragility Fracture patients in an FLS environment in Latin America (Country Specific Datasets)
Monica Calo
08:00
MR - D1
Q&A
08:00
MR - D2
Effects of mineral waters on muscle and bone
Chairpersons: Giovanni Iolascon, Silvia Migliaccio
08:00
MR - D2
Nutritional determinants of Musculoskeletal Health
Silvia Migliaccio
08:00
MR - D2
Mineral Waters and the Musculoskeletal System
Giovanni Iolascon
08:00
MR - D2
The Role of Mineral-Rich Waters in Managing Musculoskeletal Fragility: preliminary data from the FOCUS study
Antimo Moretti
08:00
MR - D2
Discussion
08:00 - 09:00
MR - C1
ESCEO-DVO Joint Symposium: Current highlights in Osteology
Chairpersons: Ralf Schmidmaier, Manju Chandran
08:00
MR - C1
One for all? Scoring of vertebral fractures?
Uwe Maus
08:20
MR - C1
Treatment induced osteoporosis in women with breast cancer - the updated position statement
Peyman Hadji
08:40
MR - C1
Fracture and Osteoporosis - Riskfactor, Endpoint, Complication,Treatment
Andreas Kurth
08:00 - 09:00
MR - D12
ESCEO Symposium: Update of the 2017 recommendations for the use of Hyaluronic Acid injections in patients with knee osteoarthritis: a patient-centered experts’ consensus
Chairpersons: François Rannou, Ali Mobasheri
08:00
MR - D12
Efficacy of IAHA in osteoarthritis
Olivier Bruyère
08:00
MR - D12
Safety of IAHA in osteoarthritis
Emmanuel Maheu
08:00
MR - D12
New perspectives in the use of IAHA for the management of osteoarthritis
Nicholas Fuggle
08:00
MR - D12
Discussion leaders
Elaine Dennison, Alberto Migliore
09:00 - 10:30
Auditorium 1
Scientific Session I
Chairpersons: Charlotte Beaudart, Peter Ebeling
09:00
Auditorium 1
Plenary Lecture
Management of very high fracture risk in the context of a lifelong osteoporosis treatment plan
Michael McClung
10:30 - 12:15
Auditorium 1
Scientific Session II
Chairpersons: Radmila Matijevic, Etienne Cavalier
10:30
Auditorium 1
Presentation of the 2026 IOF CSA Medal of Achievement
10:40
Auditorium 1
Plenary Lecture
Barriers and facilitators for orthogeriatric success
Celia Gregson
14:00 - 15:00
MR - D9
Meet-The-Expert Session
14:00
MR - D9
PTH, vitamin D and bone turnover markers from the laboratory perspective: more than you can eat!
Etienne Cavalier
14:00
MR - D8
Skeletal microarchitecture and fracture risk
Roland Chapurlat
14:00
MR - D1
FLS: current global challenges
Manju Chandran
14:00
MR - D2
Managing bone health after bariatric surgery
Bernard Cortet
14:00 - 15:00
MR- D4
Revolution in Osteoporosis Patient Care – Necessity, Opportunities, Possibilities and Results. The Czech Paradigm
Chairpersons: Eugene McCloskey, Vladimir Palicka, Richard Pikner
14:00
MR- D4
Osteoporosis Care in the Czech Republic: where we are and where we go
Vladimir Palicka
14:20
MR- D4
Czech National Population Programme for Early Detection of Osteoporosis - Methodology, Principles, and 30 Months Results
Richard Pikner
14:45
MR- D4
Discussion
14:00 - 15:00
Podium
Oral presentations of selected posters
Chairperson: Elaine Dennison
15:00 - 16:45
MR - D12
Committee of National Societies Special Plenary Session: From Research to Clinical Practice: Bridging the Gap in Bone Health
15:50
Presentation of the IOF Committee of National Societies Medal
14:00 - 15:00
MR - C1
ESCEO Symposium: GLP-1 Receptor Agonists and Musculoskeletal Health
Chairpersons: René Rizzoli, Nicholas Harvey
14:00
MR - C1
Introduction
Gulistan Bahat
14:05
MR - C1
GLP1 Receptor Agonists and bone health
Elizabeth Curtis, Nicholas Harvey
14:20
MR - C1
GLP1 Receptor Agonists and joint health
Ali Mobasheri
14:35
MR - C1
GLP1 Receptor Agonists and muscle health
Gustavo Duque
14:50
MR - C1
Discussion and conclusion
René Rizzoli
15:00 - 17:00
Auditorium 1
Scientific Session III
Chairpersons: Richard Pikner, Patricia Clark
15:00
Auditorium 1
Plenary Lecture
Hyperglycaemia and bone health: disease and therapy
Elizabeth Curtis
16:30
Auditorium 1
Plenary Lecture
Is there a role for sex hormones in the management of musculoskeletal disorders?
Tommaso Simonicini
17:00 - 18:30
Auditorium 2
Available Sponsored Satellite Symposium
* See details on the Sponsored Satellite Symposia page
18:30 - 19:30
Non-Sponsored Symposia
18:30
MR - C1
Bone Turnover Markers in CKD-Associated Osteoporosis: Translating European Consensus to Practice
Chairpersons: Maria Fusaro, Etienne Cavalier
18:30
MR - C1
Applying Bone Turnover Markers in Dialysis and Transplantation: Case-Based Insights
Thomas Nickolas
18:30
MR - C1
BALP, TRACP-5b and iPINP: New Reference Markers and Diagnostic Cut-offs in CKD
Hanne Skou Jørgensen
18:30
MR - D9
Clinical Outcomes of Sarcopenia: A GLIS Symposium
Chairpersons: Alfonso J. Cruz Jentoft, Jean-Yves Reginster
18:30
MR - D9
The Global Leadership Initiative on Sarcopenia (GLIS): objectives, structure, and achievements
Alfonso J. Cruz Jentoft
18:30
MR - D9
Health outcomes of sarcopenia: Insights from the GLIS Outcome Working Group and clinical implications
Gustavo Duque
18:30
MR - D9
Updated meta-analysis on the health outcomes of sarcopenia
Charlotte Beaudart
18:30
MR - D12
Mind Body Exercises: Yoga and its effect on Bone and Muscle Health: Myth, Magic, or Measurable Impact?
Chairperson: Ambrish Mithal
18:30
MR - D12
Introduction to Yoga and Its Relevance to Musculoskeletal Health
Manju Chandran
18:30
MR - D12
Effect of Yoga on bone mineral metabolism
Lakshmi Nagendra
18:30
MR - D12
Effect of yoga on muscle strength
Paras Bajaj
18:30
MR - D12
Yoga demonstration
18:30
MR - D12
Q&A
18:30
MR - D2
Women’s Bone Health and Hormones Therapy Update: Integrating Gynecology Into Multidisciplinary Osteoporosis Care
Chairpersons: Maria Celeste Osório Wender, Adriana Orcesi Pedro
18:30
MR - D2
Estradiol Therapy in 2026: Optimizing Type, Dose, and Route for Bone Protection Across Menopausal Stages.
Maria Celeste Osório Wender
18:30
MR - D2
Beyond Endometrial Safety: Do Different Progestogens Change Long-Term Skeletal and Metabolic Risk?
Jaime Kulak Junior
18:30
MR - D2
Androgens and the Female Musculoskeletal System: Evidence, Gaps, and the Future of Therapy.
Adriana Orcesi Pedro
18:30
MR - D2
Q&A
18:30
MR - D3
Osteoporosis in Inflammatory Diseases: Clinical Challenges and Diagnostic Gaps
Chairperson: Elena Bischoff
18:30
MR - D3
High prevalence of osteoporosis in autoimmune and inflammatory diseases
Elena Bischoff
18:30
MR - D3
Clinical Challenges and Diagnostic Gaps: REMS technology
Mira Hristova
18:30
MR- D4
Managing Bone Fragility in Older Adults with Diabetes: Pathophysiology, Assessment, and Therapeutic Considerations in Older Adults
Chairpersons: Gulistan Bahat, Dilek Gogas Yavuz
18:30
MR- D4
Pathophysiology, Risk Assessment Challenges, and Non-Pharmacological Strategies in Diabetic Bone Fragility
Tugba Erdogan
18:30
MR- D4
Skeletal Effects of Anti-Diabetic Drugs and Osteoporosis Management in Patients with Diabetes
Serdar Ozkok
18:30
MR - D1
Artificial Intelligence in Osteoporosis: What's new and what's next
Chairperson: Nicholas Fuggle
18:30
MR - D1
The Al Landscape in Bone Health 2026: From Multimodal Models to Clinical Agents
Nicholas Fuggle
18:30
MR - D1
Current ML models for predicting fracture risk - Do they meet the clinical need and if not then what are the next steps?
Bo Abrahamsen
18:30
MR - D1
Ensuring Safe, Equitable, and Regulated Al in Osteoporosis Care
Ankeet Tanna
18:30
MR - D7
Kidney and bone health in hypoparathyroidism
Chairperson: Maria Luisa Brandi
18:30
MR - D7
Kidney health in hypoparathyroidism
Jean-Philippe Bertocchio
18:30
MR - D7
Bone health in hypoparathyroidism
Aliya Khan
18:30
MR - D6
Hip Fracture and Osteoporosis
Chairperson: Christopher Niedhart
18:30
MR - D6
Hip Biomechanics and Fracture Risk: Beyond Bone Density
Andreas Kurth
18:30
MR - D6
Management of Hip Fractures – The German Approach
Katharina Michalke
18:30
MR - D6
Local Bone Augmentation to Prevent Hip Fractures
Uwe Maus